{"disease":{"id":"primary-malignant-peripheral-nerve-sheath-tumors","name":"primary malignant peripheral nerve sheath tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06693284","title":"A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"University of Minnesota","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}